SCHEMBL17366373

SCHEMBL17366373

Cc1ccc(N(c2ccc(/C=C/C=N/N(c3ccccc3)c3ccccc3)cc2)c2ccc(/C=C/C=N/N(c3ccccc3)c3ccccc3)cc2)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
HTT P42858 2/20 0.40
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
TRPM8 Q7Z2W7 2/20 0.34
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
GAA P10253 3/20 0.33
KDM4E B2RXH2 2/20 0.33
NFE2L2 Q16236 1/20 0.33
MAPT P10636 3/20 0.33
THRB P10828 2/20 0.33
MAPK1 P28482 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.32
RELA Q04206 1/20 0.32
INSR P06213 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13291600 0.84 MAOB (0.42) ALDH1A1HTTTRPM8NFE2L2MAPT
SCHEMBL13304637 0.84 MAOB (0.42) ALDH1A1HTTTRPM8NFE2L2MAPT
SCHEMBL13010108 0.84 RELA (0.44) ALDH1A1TRPM8MEN1KMT2ANFE2L2
SCHEMBL14445153 0.84 RELA (0.44) ALDH1A1TRPM8MEN1KMT2ANFE2L2
SCHEMBL4400822 0.84 RELA (0.44) ALDH1A1TRPM8MEN1KMT2ANFE2L2
SCHEMBL18993254 0.83 NFE2L2 (0.41) ALDH1A1HTTCYP3A4TRPM8MEN1
SCHEMBL15759517 0.83 APP (0.42) ALDH1A1HTTTRPM8NFE2L2MAPT
SCHEMBL17367920 0.83 ALDH1A1 (0.54) ALDH1A1HTTCYP1A2CYP3A4CYP2D6
SCHEMBL10938508 0.82 KMT2A (0.44) ALDH1A1HTTCYP1A2CYP3A4CYP2D6
SCHEMBL12677645 0.82 KMT2A (0.44) ALDH1A1HTTCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2960229-B1 HYDRAZONE DERIVATIVE OF TRIPHENYLAMINE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER KYOCERA DOCUMENT SOLUTIONS INC (JP) 2017-02-15 EP disclosed
US-9454091-B2 Hydrazone derivative of triphenylamine and electrophotographic photosensitive member KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2016-09-27 US disclosed
US-9454091-B2 Hydrazone derivative of triphenylamine and electrophotographic photosensitive member KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2016-09-27 US disclosed
US-20150378269-A1 HYDRAZONE DERIVATIVE OF TRIPHENYLAMINE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2015-12-31 US disclosed
US-20150378269-A1 HYDRAZONE DERIVATIVE OF TRIPHENYLAMINE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2015-12-31 US disclosed
EP-2960229-A1 HYDRAZONE DERIVATIVE OF TRIPHENYLAMINE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER Kyocera Document Solutions Inc. (JP) 2015-12-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150378269-A1 HYDRAZONE DERIVATIVE OF TRIPHENYLAMINE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER NAT1, GSTA1, PKN1 ALDH1A1 49/4885HTT 223/4885CYP1A2 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.